Showing results (121-130 of 333) with videos related to

Sort By:
Pageof 34
Animal Bioscience|November 25, 2025
Effects of bypass sugar supplementation from the close-up period through 5 days after calving on milk production, blood profiles, and health conditions in dairy cowsHitomi Satoh, Rika Fukumori, Moeri Kondo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2014
Inhibition of β-Catenin enhances the anticancer effect of irreversible EGFR-TKI in EGFR-mutated non-small-cell lung cancer with a T790M mutationYosuke Togashi, Hidetoshi Hayashi, Masato Terashima, et al.
Oncogenesis|October 2, 2019
Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKIKimio Yonesaka, Kaoru Tanaka, Mutsukazu Kitano, et al.
American Journal of Physiology. Cell Physiology|June 20, 2014
The NADPH oxidase inhibitor diphenyleneiodonium activates the human TRPA1 nociceptorHiroka Suzuki, Noriyuki Hatano, Yukiko Muraki, et al.
The Journal of Biological Chemistry|July 31, 2012
Hypoxia-inducible factor-1α (HIF1α) switches on transient receptor potential ankyrin repeat 1 (TRPA1) gene expression via a hypoxia response element-like motif to modulate cytokine releaseNoriyuki Hatano, Yuka Itoh, Hiroka Suzuki, et al.
Cancers|February 11, 2023
The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer CellsYuri Tozaki, Hiromasa Aoki, Rina Kato, et al.
Bioorganic & Medicinal Chemistry|July 1, 2017
Gerontoxanthone B from Maclura cochinchinensis var. gerontogea exhibits anti-inflammatory potential as an aryl hydrocarbon receptor agonistKen-Ichi Nakashima, Takumi Ogiwara, Takao Hirai, et al.
Lung Cancer (Amsterdam, Netherlands)|November 12, 2019
Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIsMasayuki Takeda, Kazuko Sakai, Hidetoshi Hayashi, et al.
Thoracic Cancer|August 17, 2019
Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancerYoshikane Nonagase, Masayuki Takeda, Koichi Azuma, et al.
FEBS Letters|January 25, 2022
The deubiquitinating enzyme USP17 regulates c-Myc levels and controls cell proliferation and glycolysisMai Nagasaka, Yasumichi Inoue, Manaka Yoshida, et al.
Pageof 34